共伴侣蛋白BAG5功能缺失突变导致需心脏移植的扩张型心肌病
研究在四个无亲缘关系的完全外显家系中发现五例遗传性扩张型心肌病(DCM)患者携带BAG5纯合截短突变;Bag5突变敲入小鼠在儿茶酚胺刺激下出现心室扩张、致心律失常性和不良预后,而AAV9载体递送野生型BAG5基因可完全改善这些DCM表型。
要点
- BAG5纯合截短突变在四个家系五例患者中导致完全外显的遗传性DCM。
- Bag5突变敲入小鼠在儿茶酚胺刺激下重现人类DCM表型。
- AAV9递送野生型BAG5基因可完全改善小鼠DCM表型。
核心结论
- BAG5功能缺失突变可导致DCM,BAG5可能成为DCM基因检测的靶点,基因治疗可能成为该病的治疗手段。
研究设计与样本
- 研究纳入四个无亲缘关系的完全外显家系中的五例遗传性DCM患者,并进行Bag5突变敲入小鼠实验。
主要发现
- 四个无亲缘关系家系中五例患者携带BAG5纯合截短突变,呈完全外显。
- Bag5突变敲入小鼠在儿茶酚胺刺激下出现心室扩张、致心律失常性和不良预后。
- 携带野生型BAG5基因的AAV9载体给药可完全改善小鼠DCM表型。
- BAG5定位于连接膜复合体(JMC),Bag5突变小鼠心肌细胞在儿茶酚胺刺激下功能性JMC蛋白丰度降低、JMC结构破坏并出现钙处理异常。
- 三例心动过速诱导性心肌病(可逆性DCM亚型,与钙稳态异常相关)患者中鉴定出杂合截短突变。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Dilated cardiomyopathy (DCM) is a major cause of heart failure, characterized by ventricular dilatation and systolic dysfunction. Familial DCM is reportedly caused by mutations in more than 50 genes, requiring precise disease stratification based on genetic information. However, the underlying genetic causes of 60 to 80% of familial DCM cases remain unknown. Here, we identified that homozygous truncating mutations in the gene encoding Bcl-2–associated athanogene (BAG) co-chaperone 5 (BAG5) caused inherited DCM in five patients among four unrelated families with complete penetrance. BAG5 acts as a nucleotide exchange factor for heat shock cognate 71 kDa protein (HSC70), promoting adenosine diphosphate release and activating HSC70-mediated protein folding. Bag5 mutant knock-in mice exhibited ventricular dilatation, arrhythmogenicity, and poor prognosis under catecholamine stimulation, recapitulating the human DCM phenotype, and administration of an adeno-associated virus 9 vector carrying the wild-type BAG5 gene could fully ameliorate these DCM phenotypes. Immunocytochemical analysis revealed that BAG5 localized to junctional membrane complexes (JMCs), critical microdomains for calcium handling. Bag5-mutant mouse cardiomyocytes exhibited decreased abundance of functional JMC proteins under catecholamine stimulation, disrupted JMC structure, and calcium handling abnormalities. We also identified heterozygous truncating mutations in three patients with tachycardia-induced cardiomyopathy, a reversible DCM subtype associated with abnormal calcium homeostasis. Our study suggests that loss-of-function mutations in BAG5 can cause DCM, that BAG5 may be a target for genetic testing in cases of DCM, and that gene therapy may potentially be a treatment for this disease.
引用
- Hakui H, Kioka H, Miyashita Y, et al. Loss-of-function mutations in the co-chaperone protein BAG5 cause dilated cardiomyopathy requiring heart transplantation. Sci Transl Med. 2022. PMID: 35044787. doi:10.1126/scitranslmed.abf3274
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。